医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
1期
52-52
,共1页
腺性膀胱炎%羟喜树碱%膀胱内灌注
腺性膀胱炎%羥喜樹堿%膀胱內灌註
선성방광염%간희수감%방광내관주
Glandular cystitis%HCPT%Intravesical
目的：总结腺性膀胱炎发病特点，探讨腺性膀胱炎电切术后应用15 mg羟喜树碱膀胱内灌注化疗预防复发的疗效及安全性。方法对78例病理证实的腺性膀胱炎患者，随机分成两组，41例行羟喜树碱膀胱内灌注（Ⅰ组），37例仅单纯电切（Ⅱ组），比较两组患者术后复发率及副反应。结果随访6～54个月，平均36个月，I组6例复发，Ⅱ组17例复发，P＜0.05，有明显统计学差异。结论腺性膀胱炎电切术后应用羟喜树碱膀胱内灌注能明显降低复发率，且副反应少。
目的：總結腺性膀胱炎髮病特點，探討腺性膀胱炎電切術後應用15 mg羥喜樹堿膀胱內灌註化療預防複髮的療效及安全性。方法對78例病理證實的腺性膀胱炎患者，隨機分成兩組，41例行羥喜樹堿膀胱內灌註（Ⅰ組），37例僅單純電切（Ⅱ組），比較兩組患者術後複髮率及副反應。結果隨訪6～54箇月，平均36箇月，I組6例複髮，Ⅱ組17例複髮，P＜0.05，有明顯統計學差異。結論腺性膀胱炎電切術後應用羥喜樹堿膀胱內灌註能明顯降低複髮率，且副反應少。
목적：총결선성방광염발병특점，탐토선성방광염전절술후응용15 mg간희수감방광내관주화료예방복발적료효급안전성。방법대78례병리증실적선성방광염환자，수궤분성량조，41례행간희수감방광내관주（Ⅰ조），37례부단순전절（Ⅱ조），비교량조환자술후복발솔급부반응。결과수방6～54개월，평균36개월，I조6례복발，Ⅱ조17례복발，P＜0.05，유명현통계학차이。결론선성방광염전절술후응용간희수감방광내관주능명현강저복발솔，차부반응소。
Objective to evaluate the therapeautic ef ect of intravesical instil ation with hydroxycamptothecinof 15mg in the cystitis glandularis after TUR. Methods seventy eight cases of pathological proven cystitis glandularis were randomized into two groups:41 cases in the first group were managed by intravesical instil ation with hydroxycamptothecin after TUR,37 cases in the second group without any drug after operation. The recurrence rates and side ef ects were examined. Results After 36 months (6~54months)fel ow-up,there is a marked dif erence between two groups on the recurrence rate. Conclusions Intravesical instil ation of mitomycin after TUR can significantly decrease the recrur-rence of cystitis glandularis,and the incidence of side ef ects was lit le.
